Register    Login Saturday, September 04, 2010
 * CTSU * Open * CALGB * CALGB 40502  
Module Border Module Border
  Research Studies 

CALGB 40502 Study Status: Open
Title: A Randomized Phase III Trial of Weekly Paclitaxel Compared to Weekly Nanoparticle Albumin Bound (Nab)-Paclitaxel or Ixabepilone Combined with Bevacizumab as First or Second-Line Therapy for Locally Recurrent or Metastatic Breast Cancer - IRB# 09-006A
Treatments: Bevacizumab, Ixabepilone, Nab-paclitaxel, Paclitaxel
Disease Site: Breast
Disease SubSite: Metastatic breast
Drug Provided: Bevacizumab, Ixabepilone, Nab-paclitaxel
Comments:
Eligibility: Histologically confirmed invasive breast cancer. Stage IIIB or IV (locally recurrent or metastatic) disease not amenable to local therapy. Measurable disease (target lesions), defined as =>1 lesion that can be accurately measured in => 1 dimension (longest diameter to be recorded) as => 2.0 cm with conventional techniques or as => 1 cm with spiral CT scan. No non-measurable lesions, including any of the following: Ascites, Pleural/pericardial effusion, Inflammatory breast disease, Lymphangitis cutis/pulmonitis, Bone lesions, Leptomeningeal disease, Cystic lesions, Abdominal masses not confirmed and followed by imaging techniques, No prior chemotherapy regimen for metastatic or locally advanced breast cancer, HER2/neu status must be known, HER2- positive disease allowed, provided patient received prior trastuzumab (Herceptin®) or lapatinib (documentation of progression on HER2-directed therapy is not required), Hormone receptor status must be known, Estrogen receptor (ER)- and progesterone receptor (PgR)-positive if => 1% cells are positive. No progressing or untreated CNS metastases or leptomeningeal disease. History of resected brain metastases with stable MRI scans for 3 months including within the past 4 weeks allowed. History of gamma-knife radiosurgery or whole-brain radiation with stable MRI scans for 3 months, including within the past 4 weeks allowed.
Participating Sites: Adventist Medical Center, Northwest Cancer Specialists, Providence Milwaukie Hospital, Providence Portland Medical Center, Providence St. Vincent Medical Center, Southwest Washington Medical Center

Module Border Module Border